Literature DB >> 18326562

Association of inflammation with anaemia in patients with chronic kidney disease not requiring chronic dialysis.

Michel Chonchol1, Giuseppe Lippi, Martina Montagnana, Michele Muggeo, Giovanni Targher.   

Abstract

BACKGROUND: Anaemia associated with chronic kidney disease (CKD) has substantial public health importance. However, the association of haemoglobin concentrations with inflammation in the setting of decreased kidney function is not well established.
METHODS: We analysed cross-sectional data from 7389 outpatient adults, who were referred by general practitioners for routine blood testing between June 2006 and June 2007. Glomerular filtration rate (eGFR) was estimated by the abbreviated Modification of Diet in Renal Disease (MDRD) equation. Multivariable linear regression analysis was used to identify factors independently associated with haemoglobin concentrations across eGFR categories as the main outcome.
RESULTS: Of the 7389 participants included in the analytic cohort 2221 (30.1%) participants had eGFR >/=90 mL/min/m(2), 4310 (58.3%) 60-89 mL/min/m(2) and 858 (11.6%) <60 mL/min/m(2). There were significant, graded, increases in high sensitivity C-reactive protein (hs-CRP) and haemoglobin concentrations across eGFR categories independent of age, gender, plasma glucose and lipids (P < 0.0001 for trends). In the multivariable regression analysis, increased hs-CRP concentrations were independently associated with lower haemoglobin concentrations at different stages of eGFR (P < 0.0001 for all). Other independent predictors of lower haemoglobin were older age, female gender and lower eGFR.
CONCLUSIONS: Our findings suggest that increased plasma hs-CRP concentrations are independently associated with anaemia in the setting of decreased kidney function in a large cohort of unselected adult outpatients.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18326562     DOI: 10.1093/ndt/gfn109

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  9 in total

1.  Longitudinal changes in hematocrit in hypertensive chronic kidney disease: results from the African-American Study of Kidney Disease and Hypertension (AASK).

Authors:  Teresa K Chen; Michelle M Estrella; Brad C Astor; Tom Greene; Xuelei Wang; Morgan E Grams; Lawrence J Appel
Journal:  Nephrol Dial Transplant       Date:  2015-03-27       Impact factor: 5.992

2.  A linear relationship between serum high-sensitive C-reactive protein and hemoglobin in hemodialysis patients.

Authors:  Behzad Heidari; Muhammad Reza Fazli; Muhammad Ali Ghazi Misaeid; Parham Heidari; Niloofar Hakimi; Abbas Ali Zeraati
Journal:  Clin Exp Nephrol       Date:  2014-11-08       Impact factor: 2.801

3.  The impact of impaired kidney function and HIV infection on the risk of anemia.

Authors:  Alison G Abraham; Frank J Palella; Xiuhong Li; Michelle M Estrella; Lawrence A Kingsley; Mallory D Witt; Lisa P Jacobson
Journal:  AIDS Res Hum Retroviruses       Date:  2012-06-29       Impact factor: 2.205

4.  Can the response to iron therapy be predicted in anemic nondialysis patients with chronic kidney disease?

Authors:  Simona Stancu; Liliana Bârsan; Ana Stanciu; Gabriel Mircescu
Journal:  Clin J Am Soc Nephrol       Date:  2009-12-17       Impact factor: 8.237

5.  Hepcidin--a potential novel biomarker for iron status in chronic kidney disease.

Authors:  Joshua Zaritsky; Brian Young; He-Jing Wang; Mark Westerman; Gordana Olbina; Elizabeta Nemeth; Tomas Ganz; Seth Rivera; Allen R Nissenson; Isidro B Salusky
Journal:  Clin J Am Soc Nephrol       Date:  2009-04-30       Impact factor: 8.237

6.  Nephrotic syndrome in diabetic kidney disease: an evaluation and update of the definition.

Authors:  Nicholas Stoycheff; Lesley A Stevens; Christopher H Schmid; Hocine Tighiouart; Julia Lewis; Robert C Atkins; Andrew S Levey
Journal:  Am J Kidney Dis       Date:  2009-06-25       Impact factor: 8.860

7.  Association between high-dose erythropoiesis-stimulating agents, inflammatory biomarkers, and soluble erythropoietin receptors.

Authors:  Jula K Inrig; Suzanne K Bryskin; Uptal D Patel; Murat Arcasoy; Lynda A Szczech
Journal:  BMC Nephrol       Date:  2011-12-12       Impact factor: 2.388

8.  Hyperphosphatemia is associated with anemia in adults without chronic kidney disease: results from the National Health and Nutrition Examination Survey (NHANES): 2005-2010.

Authors:  Janet M Wojcicki
Journal:  BMC Nephrol       Date:  2013-08-21       Impact factor: 2.388

9.  Ethnic prevalence of anemia and predictors of anemia among chronic kidney disease patients at a tertiary hospital in Johannesburg, South Africa.

Authors:  Aishatu Mohammed Nalado; Johnny N Mahlangu; Bala Waziri; Raquel Duarte; Graham Paget; Gbenga Olorunfemi; Saraladevi Naicker
Journal:  Int J Nephrol Renovasc Dis       Date:  2019-02-18
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.